Facebook
X
LinkedIn
ForwardMASAM SUD Pearls for Practice: Raising the Standard in Addiction Care Day 2
CREDIT ONLY COURSE
Jointly Provided by:
Massachusetts Society of Addiction Medicine (MASAM) & Baystate Continuing Interprofessional Education
Goal:
This program will prepare attendees to develop the knowledge, skills, and attitudes required to identify and manage substance use disorders and addiction comorbidities in their practices.This program will prepare attendees to develop the knowledge, skills, and attitudes required to identify and manage substance use disorders and addiction comorbidities in their practices. Friday will begin with a focus on Acute treatment services (ATS) level of addiction care in our state, including an update from BSAS, review of history, and panel on innovations and overcoming common challenges in providing evidence-based treatment. Friday will also include updates on methadone innovations in our state, alcohol use and hepatology, update on SUD and HCV trends in our state by DPH, and innovations in medication for opioid use disorder. Saturday will include updates on stimulant use treatment, perinatal addiction care, low barrier HIV prevention and treatment and, harm reduction innovations in our state.
Target Audience
This course is designed for: Physicians, Physician Assistants, Pharmacists, Nurse Practitioners, OTPs and other prescribers, Social Workers.
Learning Objectives
As a result of attending this educational activity, attendees should be able to:
- Identify innovative approaches to bringing HIV prevention and treatment to individuals using substances.
- Review primary literature regarding HIV prevention and treatment in this patient population and use it to inform our approach to care.
- Review the latest Massachusetts maternal mortality data and identify two ways you can improve those numbers.
- Describe how to incorporate the latest literature as you counsel patients about fentanyl, emerging substances, and MOUD in pregnancy.
- Explain how the change in Massachusetts state law regarding mandated reporting impacts your care and approach to child and family safety.
- Describe the emergence of medetomidine in the illicit drug supply.
- Explain the benefits of local drug checking in the clinical setting.
- Recognize and manage suspected medetomidine withdrawal.
- Develop a harm reduction-focused discharge plan for patients admitted with medetomidine withdrawal.
- Identify strategies for outpatient management of suspected medetomidine withdrawal.
- Define community drug checking and distinguish it from clinical toxicology and forensic drug testing.
- Describe how Tapestry combines participant knowledge, point-of-care technologies, and laboratory testing to analyze samples from the unregulated drug supply.
- Interpret individual and aggregated drug-checking findings within the limitations of submitted-sample data.
- Translate local drug-supply findings into clinical conversations, harm-reduction counseling, and care strategies.
- Describe the purpose and role of overdose prevention centers.
- Summarize the history and development of OPCs in Rhode Island and New York, and explain the OPC operating model and services provided.
- Interpret five years of OPC service and outcome data.
- Identify lessons learned from implementation and operation.
- Discuss future directions and considerations for OPCs.
- Explain why prescribing syringes to people who inject drugs (PWID) is necessary for good clinical care and harm reduction.
- Describe how to partner with local harm reductionists to create a syringe-prescribing guide customized to your community.
Course summary
- 4.25 AAPA Category 1 CME creditBaystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.25 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
- 4.25 AMA PRA Category 1 Credit™
- 4.25 ANCC Contact Hours
- 4.25 IPCE Credit Hour(s)
Individual | Individual's Role in Activity | Financial Relationship Disclosure | Discussion of |
Maria Quinn, NP | Speaker | No relevant relationships with ineligible companies to disclose | No |
Josh St. Louis, MD, MPH, AAHIVS | Panelist | No relevant relationships with ineligible companies to disclose | No |
Morgan Younkin, MD | Panelist | No relevant relationships with ineligible companies to disclose | No |
Patrick Salemme, MD | Panelist | No relevant relationships with ineligible companies to disclose | No |
Jessica Gray, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Pedro Alvarez, BS, | Speaker | No relevant relationships with ineligible companies to disclose | No |
Kyle Harrington, MPH | Speaker | No relevant relationships with ineligible companies to disclose | No |
Alexi Guzman | Speaker | No relevant relationships with ineligible companies to disclose | No |
Cara Zimmerman, MD, MBA | Speaker | No relevant relationships with ineligible companies to disclose | No |
Benjamin Hayes, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Ruchi Shah, DO | Speaker | No relevant relationships with ineligible companies to disclose | No |
Michael Yang, MD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Joseph Shay | Speaker | No relevant relationships with ineligible companies to disclose | No |
POLICY ON FACULTY AND SPONSOR DISCLOSURE
The design and content of Baystate Continuing Interprofessional Education (CE) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Any relevant financial relationships are mitigated prior to the educational activity.
None of the planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
In support of improving patient care, Baystate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
Baystate Continuing Interprofessional Education designates this live activity for a maximum of 5.00 AMA PRA Category 1 Credit(s)TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Nurses
Baystate Continuing Interprofessional Education designates this live activity for a maximum of 5.00 contact hour(s). Nurses should only claim the credit commensurate with the extent of their participation in the activity.
AAPA Credit Designation Statement
AAPA accepts AMA category 1 credit for the PRA from organizations accredited by ACCME. Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.0 AAPA Category 1 CME credit(s). PA’s should only claim credit commensurate with the extent of their participation.
This activity was planned by and for the healthcare team and learners will receive 5.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
Available Credit
- 4.25 AAPA Category 1 CME creditBaystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.25 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
- 4.25 AMA PRA Category 1 Credit™
- 4.25 ANCC Contact Hours
- 4.25 IPCE Credit Hour(s)